A successful anticoagulation protocol for the first HeartMate II implantation in the United States

Tex Heart Inst J. 2005;32(3):399-401.

Abstract

Bleeding and thrombus formation are common problems with life-threatening implications in patients receiving a left ventricular assist device. We describe the anticoagulation protocol for the 1st patient in the United States to undergo successful implantation of the HeartMate II left ventricular assist system.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / administration & dosage
  • Anticoagulants / therapeutic use*
  • Antithrombins / administration & dosage
  • Antithrombins / therapeutic use
  • Dextrans / administration & dosage
  • Dextrans / therapeutic use
  • Drug Therapy, Combination
  • Follow-Up Studies
  • Heart-Assist Devices*
  • Hirudins / administration & dosage
  • Humans
  • Infusions, Intravenous
  • Male
  • Peptide Fragments / administration & dosage
  • Peptide Fragments / therapeutic use
  • Prosthesis Implantation / adverse effects
  • Prosthesis Implantation / methods*
  • Recombinant Proteins / administration & dosage
  • Recombinant Proteins / therapeutic use
  • Shock, Cardiogenic / therapy*
  • Thromboembolism / etiology
  • Thromboembolism / prevention & control*

Substances

  • Anticoagulants
  • Antithrombins
  • Dextrans
  • Hirudins
  • Peptide Fragments
  • Recombinant Proteins
  • bivalirudin